statistiche ricercatore

MANCINI, NICASIO

Distribuzione geografica

Continente	#
NA - Nord America	5.906
EU - Europa	3.975
AS - Asia	3.906
SA - Sud America	443
AF - Africa	94
OC - Oceania	12
Continente sconosciuto - Info sul continente non disponibili	2
Totale	14.338

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	5.718
IT - Italia	2.357
SG - Singapore	1.740
CN - Cina	778
HK - Hong Kong	597
BR - Brasile	377
VN - Vietnam	371
GB - Regno Unito	284
FR - Francia	248
DE - Germania	213
RU - Federazione Russa	178
FI - Finlandia	165
IE - Irlanda	156
IN - India	106
CA - Canada	97
UA - Ucraina	91
TR - Turchia	78
MX - Messico	75
SE - Svezia	72
BD - Bangladesh	44
JP - Giappone	44
AT - Austria	39
PL - Polonia	38
NL - Olanda	36
IQ - Iraq	28
ES - Italia	27
ZA - Sudafrica	26
AR - Argentina	25
NG - Nigeria	23
SA - Arabia Saudita	21
BE - Belgio	18
LT - Lituania	18
KE - Kenya	11
PK - Pakistan	11
AE - Emirati Arabi Uniti	10
CH - Svizzera	10
AU - Australia	9
MA - Marocco	9
UZ - Uzbekistan	9
CO - Colombia	8
ID - Indonesia	8
JO - Giordania	8
MY - Malesia	8
VE - Venezuela	8
EC - Ecuador	7
AZ - Azerbaigian	6
CL - Cile	6
PH - Filippine	6
TN - Tunisia	6
EG - Egitto	5
IL - Israele	5
PE - Perù	5
ET - Etiopia	4
GR - Grecia	4
LB - Libano	4
BB - Barbados	3
BH - Bahrain	3
CI - Costa d'Avorio	3
CR - Costa Rica	3
GT - Guatemala	3
KR - Corea	3
NO - Norvegia	3
TT - Trinidad e Tobago	3
UY - Uruguay	3
BG - Bulgaria	2
BY - Bielorussia	2
CZ - Repubblica Ceca	2
EE - Estonia	2
EU - Europa	2
IR - Iran	2
KH - Cambogia	2
KZ - Kazakistan	2
PY - Paraguay	2
QA - Qatar	2
RS - Serbia	2
RW - Ruanda	2
SI - Slovenia	2
TH - Thailandia	2
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AO - Angola	1
BN - Brunei Darussalam	1
BO - Bolivia	1
BZ - Belize	1
CG - Congo	1
DK - Danimarca	1
GA - Gabon	1
GE - Georgia	1
GN - Guinea	1
GY - Guiana	1
HN - Honduras	1
IM - Isola di Man	1
KG - Kirghizistan	1
MD - Moldavia	1
NC - Nuova Caledonia	1
NI - Nicaragua	1
NP - Nepal	1
NZ - Nuova Zelanda	1
OM - Oman	1
PA - Panama	1
Totale	14.332

Salva come PNG Salva come JPEG

Città	#
Milan	1.411
San Jose	1.133
Singapore	937
Ashburn	638
Hong Kong	586
Dallas	449
Chicago	442
Beijing	289
The Dalles	243
Boardman	214
Lauterbourg	179
London	176
Council Bluffs	174
Los Angeles	157
Dublin	151
Fairfield	141
Rome	133
Ho Chi Minh City	109
Helsinki	107
Varese	104
Chandler	94
Hanoi	84
New York	81
Seattle	80
Santa Clara	73
Jacksonville	72
Munich	71
Como	60
Houston	58
Salt Lake City	57
Woodbridge	55
Frankfurt am Main	52
Wilmington	52
Ogden	49
Mexico City	47
Washington	44
Chennai	43
Brooklyn	42
Ann Arbor	41
Tokyo	39
Toronto	39
Orem	38
Nyköping	35
São Paulo	33
Warsaw	33
Cambridge	32
Tampa	32
Guangzhou	30
Princeton	30
Vienna	29
Izmir	26
Magnago	26
Nuremberg	26
Atlanta	24
Lancaster	24
Abuja	23
Boston	23
Dearborn	23
Denver	23
Elk Grove Village	23
Montreal	23
Da Nang	22
Johannesburg	20
Phoenix	20
San Francisco	20
San Diego	18
Shanghai	18
Shenzhen	18
Amsterdam	17
Brussels	17
Buffalo	17
Haiphong	16
West Jordan	16
Rio de Janeiro	15
Stockholm	14
Belo Horizonte	13
Dhaka	13
Lappeenranta	13
Poplar	13
Vancouver	13
Ankara	12
Assago	12
Manchester	12
Mumbai	12
New Delhi	12
Turku	12
Nairobi	11
Pune	11
Sterling	11
Hangzhou	10
Baghdad	9
Charlotte	9
Dulles	9
Düsseldorf	9
Jeddah	9
Berlin	8
Detroit	8
Dong Ket	8
Pittsburgh	8
Riyadh	8
Totale	10.075

Salva come PNG Salva come JPEG

Nome	#
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy	463
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.	195
Coronaviridae and SARS-associated coronavirus strain HSR1.	193
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.	179
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.	178
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).	171
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	163
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.	162
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age	160
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.	158
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021	158
A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice	153
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.	138
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	135
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells	126
A biologically-validated HCV E1E2 heterodimer structural model	118
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.	116
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples	112
Phage display for the production of human monoclonal antibodies against human pathogens.	111
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	109
Humoral immune response against hepatitis C virus.	108
Type III interferons disrupt the lung epithelial barrier upon viral recognition	106
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	105
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	104
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).	104
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	103
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	103
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	99
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	99
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	99
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	97
A modified Frosch approach for posterior tibial plateau fractures: technical note and case series	97
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	96
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine	96
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	94
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	94
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	93
The IN SIGNO project: Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	92
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	90
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	90
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing	89
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening	89
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	89
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	88
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation	88
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	87
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era	87
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models	87
Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience	86
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	86
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	86
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review	85
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy	85
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	84
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	84
Answer to photo quiz: Streptococcus pneumoniae	83
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB	83
Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022–2023	82
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	82
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19	81
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	81
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	81
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota	80
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	80
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	79
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients	79
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols	79
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	79
A closer look at prion strains: characterization and important implications	78
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals	78
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity	78
Epidemiological characteristics of non-polio enteroviruses in respiratory infections: An Italian multicentre retrospective study, 2022–2023	77
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition	77
The interferon landscape along the respiratory tract impacts the severity of COVID-19	77
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay	76
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020	76
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	75
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	74
Molecular characterization of emerging Echovirus 11 (E11) shed light on the recombinant origin of a variant associated with severe hepatitis in neonates	74
Viral respiratory pathogens and lung Injury	74
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	73
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	73
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	72
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	72
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	71
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital	71
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	71
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	70
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19	70
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	68
Risks of "blind" automated identification systems in medical microbiology	68
Torquetenovirus Viremia Quantification Using Real-Time PCR Developed on a Fully Automated, Random-Access Platform	68
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection	68
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	68
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: An IFCC global survey	68
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects	67
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital	67
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence	66
IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2	66
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey	64
Totale	9.911

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	73.244
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	73.244

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	41	0	0	0	0	0	0	0	0	0	0	16	25
2021/2022	219	11	43	20	17	4	0	35	21	16	21	11	20
2022/2023	704	19	7	13	34	34	52	0	39	267	129	35	75
2023/2024	2.699	371	395	336	500	572	254	23	55	79	66	12	36
2024/2025	3.254	24	58	629	141	102	159	134	134	353	184	465	871
2025/2026	7.259	594	409	616	987	541	292	1.857	436	961	550	16	0
Totale													14.831